[144] Affirm Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

Affirm Holdings, Inc. (AFRM) Form 144 notice shows a proposed sale of 22,725 common shares (restricted stock units) by the holder, with an approximate aggregate market value of $1,817,772.75 and an intended sale date of 08/29/2025 on NASDAQ. The shares were acquired as RSUs on 01/01/2024 and the filing reports 284,917,717 shares outstanding for the issuer, providing context for the sale size relative to the company’s share count.

The filing also discloses prior 10b5-1 sales by the same person: 15,871 shares sold on 08/04/2025 generating $1,190,325.00 in gross proceeds. The filer attests they are not aware of any undisclosed material adverse information at the time of signing and notes reliance on Rule 10b5-1 for prior sales. The notice is a regulatory disclosure of an insider’s planned disposition and past 10b5-1 sales, without additional financial performance data.

Positive

• Regulatory transparency: The filing discloses planned and recent insider sales with dates, quantities, and proceeds.
• Use of 10b5-1 plan disclosed: Prior sales executed under a 10b5-1 plan are reported, clarifying the mechanism for prior disposals.

Negative

• Insider selling activity: Proposed sale of 22,725 shares (~$1.82M) and recent sale of 15,871 shares may be viewed negatively by some investors despite being routine.

Insights

Securities Analyst

TL;DR: Insider proposes a modest RSU sale (22,725 shares, ~$1.82M) and completed 10b5-1 sales earlier in August.

The Form 144 documents a planned sale of 22,725 RSUs acquired 01/01/2024, valued at about $1.82M, against an outstanding share base of 284.9M which makes the sale small in percentage terms. The filing also reports a completed 10b5-1 sale of 15,871 shares on 08/04/2025 for $1.19M. This is a routine insider disposition disclosure that provides transparency but does not include operational or earnings data to change company valuation models.

Corporate Governance Expert

TL;DR: Filing meets disclosure requirements; shows use of 10b5-1 plan and attestation about material non-public information.

The notice includes the signer’s representation of no undisclosed material adverse information and cites a 10b5-1 plan for prior sales, which are governance-relevant details. The planned sale and prior executed sales are documented with dates, quantities, and proceeds, supporting compliance and market transparency. The filing contains no indications of regulatory issues or withheld material facts within the document itself.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	22725	1817772.75	284917717	08/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2024	Restricted Stock Units	Issuer			22725	01/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SIPHELELE N JIYANE 650 California Street San Francisco CA 94108	Common	08/04/2025	15871	1190325.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider sale does the AFRM Form 144 disclose?

The notice reports a proposed sale of 22,725 common shares (RSUs) with an aggregate market value of $1,817,772.75, intended for 08/29/2025 on NASDAQ.

When were the shares being sold originally acquired?

The securities were acquired as Restricted Stock Units on 01/01/2024 with an acquired quantity of 22,725 shares.

Did the filer sell any AFRM shares recently?

Yes. The filing shows a 10b5-1 sale of 15,871 shares on 08/04/2025 that generated $1,190,325.00 in gross proceeds.

How large is the planned sale relative to outstanding shares?

The issuer reports 284,917,717 shares outstanding; the planned sale of 22,725 shares represents a small fraction of the outstanding share count.

Does the filing state any undisclosed material information?

The signer represents by signature that they do not know of any material adverse information about the issuer that has not been publicly disclosed.